Elevation Oncology falls after early-stage data for lead cancer drug
Elevation Oncology (ELEV) stock drops as initial data from a Phase 1 trial for its lead cancer drug EO-3021 reveals adverse ...
Business Insider10d
Buy Rating Affirmed for Elevation Oncology Amid Promising EO-3021 Phase 1 Results and Strategic Development Approach
H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Elevation Oncology (ELEV – Research Report ... Ramakanth also noted the strategic approach to drug development, including ...
Vinesh Phogat CAS Hearing Highlights: ‘Will be really good if she gets the medal,’ says Neeraj Chopra
The Court of Arbitration for Sports decision on wrestler Vinesh Phogat's plea against her disqualification at Paris Olympics ...
LTIMindtree and HCL Tech could rally 15-27% in 1 year: Positioned for strong growth amid GCC expansion
Global Capability Centers in India have experienced substantial growth over the past decade. From FY15 to FY23, GCC revenues ...
Ola Electric Share Price Live Updates: Stock settles 19% higher on listing day; Should you book profit, hold or buy?
Ola Electric share price jumped more than 19 per cent after making a flat stock market debut. Ola Electric shares were listed ...
Die Goldseiten9d
Goliath Receives Lead Order From Strategic Investor Crescat Capital For Expanded Drill Program At Surebet Discovery
Goliath Resources Ltd. is pleased to report it has received a lead order from its strategic investor, Crescat Capital LLC, the Company's single largest shareholder. Goliath intends to raise up to ...
Die Goldseiten9d
Goliath Receives Lead Order From Strategic Investor Crescat Capital For Expanded Drill ...
Goliath Resources Ltd. is pleased to report it has received a lead order from its strategic investor, Crescat Capital LLC, the Company's single largest shareholder. Goliath intends to raise up to ...